Impact Factor Journals 2023

LOFFELMANN, M., Z. ŠKROTT, D. MAJERA, P. STARHA, V. KRYŠTOF, M. MISTRÍK

Identification of novel dithiocarbamate-copper complexes targeting p97/NPL4 pathway in cancer cells. European Journal of Medicinal Chemistry. 2023, 261, 115790, ISSN: 0223-5234 , PMID: 37690264,

GIACCHERINI, M., L. GORI, M. GENTILUOMO, R. FARINELLA, K. CERVENA, J. SKIECEVICIENE, F. DIJK, G. CAPURSO, A. VEZAKIS, L. ARCHIBUGI, R. CHAMAS, T. HUSSEIN, F. TAVANO, P. HEGYI, M. LOVEČEK, J. IZBICKY, H. BRENNER, B. MOHELNÍKOVÁ DUCHOŇOVÁ, G. DELL´ANNA, J. KUPCINSKAS, S. ERMINI, M. NOBREGA AOKI, J. NEOPTOLEMOS, M. GAZOULI, C. PASQUALI, R. PEZZILLLI, R. TALAR-WOJNAROWSKA, M. OLIVERIUS, M. AL-SAEEDI, M. LUCCHESI, N. FURBETTA, S. CARRARA, C. VAN EIJCK, A. MALECKAS, A. MILANETTO, R. LAWLOR, B. SCHOTTKER, U. BOGGI, L. MORELLI, L. GINOCCHI, R. PONZ DE LEON, C. SPERTI, A. ZERBI, L. ARCIDIACONO, F. UZUNOGLU, B. HOLLECZEK, D. GIOFFREDA, E. MALECKA-WOJCIESKO, M. KIUDELIS, A. SZENTESI, H. VAN LAARHOVEN, P. SOUCEK, M. GOTZ, B. EROSS, G. CAVESTRO, D. BASSO, F. PERRI, S. LANDI, F. CANZIAN, D. CAMPA

A scan of all coding region variants of the human genome, identifies 13q12.2-rs9579139 and 15q24.1-rs2277598 as novel risk loci for pancreatic ductal adenocarcinoma. Carcinogenesis. 2023, ISSN: 0143-3334, PMID: 37670727,

VECERA, L., P. PRASIL, J. SROVNAL, E. BERTA, M. VIDLAŘOVÁ, T. GABRHELIK, P. KOUŘILOVÁ, M. LOVEČEK, P. SKALICKÝ, J. ŠKARDA, Z. KALA, P. MICHALEK, M. HAJDÚCH

Morphine Analgesia, Cannabinoid Receptor 2, and Opioid Growth Factor Receptor Cancer Tissue Expression Improve Survival after Pancreatic Cancer Surgery. Cancers. 2023, 15(16), 4038, ISSN: 2072-6694, PMID: 37627066, PDF.

LEMBERG, K., E. ALI, M. KRECMEROVA, J. AGULIAR, J. ALT, D. PETERS, L. ZHAO, Y. WU, N. NUHA, J. ASARA, V. STAEDTKE, C. PRATILAS, P. MAJER, R. RAIS, I. BEN-SAHRA

Pro-905, a Novel Purine Antimetabolite, Combines with Glutamine Amidotransferase Inhibition to Suppress Growth of Malignant Peripheral Nerve Sheath Tumor. Molecular Cancer Therapeutics. 2023, 22(12), 1390-1403, ISSN: 1535-7163, PMID: 37616542,

KAPLANEK, R., Z. KEJIK, J. HAJDUCH, K. VESELA, K. KUCNIROVA, M. SKALICKOVA, A. VENHAUEROVA, B. HOSNEDLOVA, R. HROMADKA, P. DYTRYCH, P. NOVOTNY, N. ABRAMENKO, V. ANTONYOVA, D. HOSKOVEC, P. BABULA, M. MASARIK, P. MARTASEK, M. JAKUBEK

TET protein inhibitors: Potential and limitations. Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie. 2023, 166, 115324, ISSN: 0753-3322, PMID: 37598475.

KAHOUNOVA, Z., M. PICKOVA, S. DRAPELA, J. BOUCHAL, E. SZCZYRBOVA, J. NAVRATIL, K. SOUCEK

Circulating tumor cell-derived preclinical models: current status and future perspectives. Cell Death & Disease. 2023, 14(8), 530, ISSN: 2041-4889, PMID: 37591867,

JESETA, M., A. POSPISILOVA, L. MEKINOVA, K. FRANZOVA, P. VENTRUBA, E. LOUSOVA, B. KEMPISTY, T. OŽDIAN, J. ZAKOVA, I. CRHA

Non-Invasive Diagnostics of Male Spermatogenesis from Seminal Plasma: Seminal Proteins. Diagnostics (Basel, Switzerland). 2023, 13(15), 2468, ISSN: 2075-4418, PMID: 37568830, PDF.

CHEN, G., H. WANG, L. BUMBA, J. MASIN, P. SEBO, L. HONGBIN

The adenylate cyclase toxin RTX domain follows a series templated folding mechanism with implications for toxin activity. The Journal of Biological Chemistry. 2023, 299(9), 105150, ISSN: 0021-9258, PMID: 37567473,

HRUBÁ, L., V. DAS, M. HAJDÚCH, P. DŽUBÁK

Nucleoside-based anticancer drugs: mechanism of action and drug resistance. Biochemical Pharmacology. 2023, ISSN: 0006-2952 , PMID: 37567317, PDF.

PETERS, D., L. NORRIS, L. TENORA, I. SNAJDR, A. PONTI, X. ZHU, S. SAKAMOTO, V. VEERVALLI, M. PRADHAN, J. ALT et al.

A gut-restricted glutamate carboxypeptidase II inhibitor reduces monocytic inflammation and improves preclinical colitis. Science Translational Medicine. 2023, 15(708), eabn7491, ISSN: 1946-6234, IF: 17.1, PMID: 37556558.